We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

838 hedge funds and large institutions have $25.5B invested in Edwards Lifesciences in 2018 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 286 increasing their positions, 314 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 54

11% more call options, than puts

Call options by funds: $152M | Put options by funds: $136M

5% more funds holding in top 10

Funds holding in top 10: 21 → 22 (+1)

3% more funds holding

Funds holding: 815 → 838 (+23)

5% more capital invested

Capital invested by funds: $24.3B → $25.5B (+$1.16B)

0.55% more ownership

Funds ownership: 249.42% → 249.97% (+0.55%)

9% less repeat investments, than reductions

Existing positions increased: 286 | Existing positions reduced: 314

Holders
838
Holders Change
+23
Holders Change %
+2.82%
% of All Funds
19.18%
Holding in Top 10
22
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.76%
% of All Funds
0.5%
New
82
Increased
286
Reduced
314
Closed
54
Calls
$152M
Puts
$136M
Net Calls
+$15.6M
Net Calls Change
-$6.4M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$233M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$187M
3
TCIM
TIAA CREF Investment Management
New York
+$109M
4
WCM Investment Management
WCM Investment Management
California
+$63.4M
5
Invesco
Invesco
Georgia
+$57M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$88.9M
2
Ameriprise
Ameriprise
Minnesota
-$80.6M
3
Renaissance Technologies
Renaissance Technologies
New York
-$71.7M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$71.7M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$70.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$84.1M +$2.27M +48,690 +3%
MC
52
Montag & Caldwell
Georgia
$83M -$51.1M -1,094,589 -39%
CTA
53
Carillon Tower Advisers
Florida
$80.7M +$25.6M +547,806 +49%
DZ Bank
54
DZ Bank
Germany
$79.9M +$3.03M +64,884 +4%
Primecap Management
55
Primecap Management
California
$77.9M – – –
Adage Capital Partners
56
Adage Capital Partners
Massachusetts
$73.6M -$32.2M -689,325 -31%
PHS
57
PFM Health Sciences
California
$73.3M -$7.95M -170,250 -10%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$72.1M -$5.49M -117,600 -7%
Renaissance Technologies
59
Renaissance Technologies
New York
$72M -$71.7M -1,537,200 -51%
Baird Financial Group
60
Baird Financial Group
Wisconsin
$67.3M -$910K -19,500 -1%
WCM Investment Management
61
WCM Investment Management
California
$66.3M +$63.4M +1,359,093 +19,311%
Principal Financial Group
62
Principal Financial Group
Iowa
$64.4M -$2.7M -57,741 -4%
Prudential Financial
63
Prudential Financial
New Jersey
$64.2M -$11M -236,382 -15%
Mitsubishi UFJ Trust & Banking
64
Mitsubishi UFJ Trust & Banking
Japan
$63M -$2.95M -63,252 -5%
Arrowstreet Capital
65
Arrowstreet Capital
Massachusetts
$62.8M +$15M +321,867 +33%
Korea Investment Corp
66
Korea Investment Corp
South Korea
$60.7M +$1.51M +32,400 +3%
CS
67
Credit Suisse
Switzerland
$60.6M +$2.1M +44,967 +4%
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$59.5M +$2.06M +44,190 +4%
D.E. Shaw & Co
69
D.E. Shaw & Co
New York
$59.5M -$10.3M -221,205 -15%
PNC Financial Services Group
70
PNC Financial Services Group
Pennsylvania
$59.4M -$5.22M -111,834 -8%
California Public Employees Retirement System
71
California Public Employees Retirement System
California
$59M -$7.01M -150,084 -11%
T. Rowe Price Associates
72
T. Rowe Price Associates
Maryland
$53.9M +$227K +4,866 +0.4%
First Trust Advisors
73
First Trust Advisors
Illinois
$53.1M +$44.1M +945,432 +634%
STMM
74
South Texas Money Management
Texas
$52.1M +$976K +20,916 +2%
Victory Capital Management
75
Victory Capital Management
Texas
$51.3M -$1.68M -35,967 -3%
1 2
3
4 5

EW Hedge Fund Activity: Q2 2018 in Review

838 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2018, worth a combined $25.5B — up 4.8% from $24.3B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new EW positions and 54 closed out — a net gain of 28 holders — while 286 added to existing stakes and 314 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $233M. The largest seller was Goldman Sachs, cutting an estimated $88.9M.

  • 838 institutional investors held Edwards Lifesciences (EW) as of Q2 2018, up from 815 in Q1 2018.
  • Funds reported $25.5B of Edwards Lifesciences stock for Q2 2018, up 4.8% quarter-over-quarter.
  • 82 funds opened new Edwards Lifesciences positions in Q2 2018 and 54 closed out, a net change of +28 holders.
  • The largest Edwards Lifesciences buyer in Q2 2018 was Fidelity Investments, an estimated $233M added.
  • The largest Edwards Lifesciences seller in Q2 2018 was Goldman Sachs, an estimated $88.9M sold.

Based on aggregated 13F filings for Q2 2018.